Helio Genomics, a leading AI-powered TechBio company focused on revolutionizing early cancer detection, today announced a strategic commercial partnership with Syneos Health®, a leading fully ...

A study led by Dr Jason Pitt, Principal Investigator at the Cancer Science Institute of Singapore (CSI Singapore), has ...

Predictive genomics enhances breast cancer management by integrating predictive medicine, personal genomics, and translational bioinformatics for personalized care. Key applications include ...

The Food and Drug Administration approved Guardant Health's newest blood cancer test Wednesday, and the stock leaped to a three-month high.

Why do two people with the same cancer diagnosis—the same stage, the same cell type, and the same clinical profile—often have ...

In 2022, NIST started the Cancer Genome in a Bottle program as part of a major partnership between government, universities and industry to focus on fighting cancer. Specifically, the goal of the ...

Insights derived from one of the largest datasets with over 250 million harmonized variant calls from over 8,000 tumor-normal whole genomes from more than 30 different cancer types will be presented ...

A protein doctors routinely use to measure how aggressively tumors are growing may also help prevent the chromosome errors ...

In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...